Skip to main content
The British Journal of Venereal Diseases logoLink to The British Journal of Venereal Diseases
. 1978 Dec;54(6):400–402. doi: 10.1136/sti.54.6.400

Clinical experience in the use of cefuroxime in gonorrhoea.

W Fowler, G Rahim, J D Brown
PMCID: PMC1045558  PMID: 737517

Abstract

Cefuroxime, a new antibiotic derived from cephalosporin-C which is very stable in the presence of beta-lactamases produced by Gram-negative organisms, was used to treat 856 male patients and 340 female patients with uncomplicated gonorrhoea. In men the drug was used in three different doses, 1.5 g, 1 g, and 750 mg plus 1 g probenecid; in women 1 g and 750 mg cefuroxime plus 1 g probenecid was used. Cure rates ranged from 94.8% to 99.3%. The antibiotic was well tolerated and was free from side effects. Cefuroxime would be a valuable and efficient substitute for penicillin in the treatment of gonorrhoea due to beta-lactamase-producing strains of gonococci.

Full text

PDF
400

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashford W. A., Golash R. G., Hemming V. G. Penicillinase-producing Neisseria gonorrhoeae. Lancet. 1976 Sep 25;2(7987):657–658. doi: 10.1016/s0140-6736(76)92467-3. [DOI] [PubMed] [Google Scholar]
  2. Lynn R., Nicol C. S., Ridley M., Rimmer D., Symonds M. A., Warren C. Further studies of penicillin resistant gonococci. Br J Vener Dis. 1970 Oct;46(5):404–405. doi: 10.1136/sti.46.5.404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Phillips I. Beta-lactamase-producing, penicillin-resistant gonococcus. Lancet. 1976 Sep 25;2(7987):656–657. doi: 10.1016/s0140-6736(76)92466-1. [DOI] [PubMed] [Google Scholar]
  4. WILLCOX R. R. AMPICILLIN BY INJECTION AND BY MOUTH IN THE TREATMENT OF ACUTE GONORRHOEA. Br J Vener Dis. 1964 Dec;40:261–265. doi: 10.1136/sti.40.4.261. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Venereal Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES